Six to twelve months after
traditional antibiotic therapy, many people have non-objective symptoms that return with varying intensity and no current treatment strategy, known as Post-Treatment Lyme Disease Syndrome.
Not exact matches
If these peptides are developed for therapeutic use, the researchers anticipate that they could be used either in stand - alone
therapy or together with
traditional antibiotics, which would make it more difficult for bacteria to evolve drug resistance.